Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Xentuzumab Biosimilar – Anti-IGF1, IGF2 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, lambda |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Xentuzumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade |
|---|---|
| Source | CAS 1417158-65-6 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Xentuzumab,BI 836845,IGF1, IGF2 ,anti-IGF1, IGF2 |
| Reference | PX-TA1409 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-lambda |
| Clonality | Monoclonal Antibody |
Description of Xentuzumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade
General information on Anti-IGF1/IGF2 [Homo sapiens] (Xentuzumab) Monoclonal Antibody
Xentuzumab is investigated for the treatment of Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC).
SDS-PAGE for Xentuzumab Biosimilar - Anti-IGF1, IGF2 mAb
Xentuzumab Biosimilar - Anti-IGF1, IGF2 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Antigen
Human IGF1 recombinant protein
PX-P6251 420€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.